Suppr超能文献

用于胞外5'-核苷酸酶(CD73)的荧光探针。

Fluorescent Probes for Ecto-5'-nucleotidase (CD73).

作者信息

Schmies Constanze C, Rolshoven Georg, Idris Riham M, Losenkova Karolina, Renn Christian, Schäkel Laura, Al-Hroub Haneen, Wang Yulu, Garofano Francesca, Schmidt-Wolf Ingo G H, Zimmermann Herbert, Yegutkin Gennady G, Müller Christa E

机构信息

PharmaCenter Bonn, Pharmaceutical Institute, Department of Pharmaceutical & Medicinal Chemistry, University of Bonn, An der Immenburg 4, D-53121 Bonn, Germany.

MediCity Research Laboratory, University of Turku, 20520 Turku, Finland.

出版信息

ACS Med Chem Lett. 2020 Sep 3;11(11):2253-2260. doi: 10.1021/acsmedchemlett.0c00391. eCollection 2020 Nov 12.

Abstract

Ecto-5'-nucleotidase (CD73) catalyzes the hydrolysis of AMP to anti-inflammatory, immunosuppressive adenosine. It is expressed on vascular endothelial, epithelial, and also numerous cancer cells where it strongly contributes to an immunosuppressive microenvironment. In the present study we designed and synthesized fluorescent-labeled CD73 inhibitors with low nanomolar affinity and high selectivity based on benzyl-α,β-methylene-ADP (PSB-12379) as a lead structure. Fluorescein was attached to the benzyl residue via different linkers resulting in PSB-19416 (, 12.6 nM) and PSB-18332 (, 2.98 nM) as fluorescent high-affinity probes for CD73. These compounds are anticipated to become useful tools for biological studies, drug screening, and diagnostic applications.

摘要

胞外5'-核苷酸酶(CD73)催化AMP水解为具有抗炎、免疫抑制作用的腺苷。它在血管内皮细胞、上皮细胞以及众多癌细胞上表达,在这些细胞中它对免疫抑制微环境有重要作用。在本研究中,我们基于苄基-α,β-亚甲基-ADP(PSB-12379)作为先导结构,设计并合成了具有低纳摩尔亲和力和高选择性的荧光标记CD73抑制剂。荧光素通过不同的连接子连接到苄基残基上,得到了PSB-19416(,12.6 nM)和PSB-18332(,2.98 nM)作为CD73的荧光高亲和力探针。预计这些化合物将成为生物学研究、药物筛选和诊断应用的有用工具。

相似文献

1
Fluorescent Probes for Ecto-5'-nucleotidase (CD73).
ACS Med Chem Lett. 2020 Sep 3;11(11):2253-2260. doi: 10.1021/acsmedchemlett.0c00391. eCollection 2020 Nov 12.
2
α,β-Methylene-ADP (AOPCP) Derivatives and Analogues: Development of Potent and Selective ecto-5'-Nucleotidase (CD73) Inhibitors.
J Med Chem. 2015 Aug 13;58(15):6248-63. doi: 10.1021/acs.jmedchem.5b00802. Epub 2015 Jul 30.
3
Methotrexate up-regulates ecto-5'-nucleotidase/CD73 and reduces the frequency of T lymphocytes in the glioblastoma microenvironment.
Purinergic Signal. 2016 Jun;12(2):303-12. doi: 10.1007/s11302-016-9505-8. Epub 2016 Feb 24.
4
Ecto-5'-nucleotidase and intestinal ion secretion by enteropathogenic Escherichia coli.
Purinergic Signal. 2007 Jun;3(3):233-46. doi: 10.1007/s11302-007-9056-0. Epub 2007 May 17.
5
The role of ecto-5'-nucleotidase in endothelial dysfunction and vascular pathologies.
Pharmacol Rep. 2015 Aug;67(4):675-81. doi: 10.1016/j.pharep.2015.05.002. Epub 2015 May 16.
6
Activity and expression of ecto-5'-nucleotidase/CD73 are increased by thyroid hormones in vascular smooth muscle cells.
Mol Cell Biochem. 2006 Sep;289(1-2):65-72. doi: 10.1007/s11010-006-9148-0. Epub 2006 May 23.
8
Involvement of CD73 (ecto-5'-nucleotidase) in adenosine generation by human gingival fibroblasts.
J Dent Res. 2003 Nov;82(11):888-92. doi: 10.1177/154405910308201108.
10
The role of ecto-5'-nucleotidase/CD73 in glioma cell line proliferation.
Mol Cell Biochem. 2008 Dec;319(1-2):61-8. doi: 10.1007/s11010-008-9877-3. Epub 2008 Jul 18.

引用本文的文献

1
CD73: agent development potential and its application in diabetes and atherosclerosis.
Front Immunol. 2024 Dec 12;15:1515875. doi: 10.3389/fimmu.2024.1515875. eCollection 2024.
2
CD73: Friend or Foe in Lung Injury.
Int J Mol Sci. 2023 Mar 14;24(6):5545. doi: 10.3390/ijms24065545.
3
ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain.
Pharmacol Rev. 2022 Jul;74(3):797-822. doi: 10.1124/pharmrev.121.000528.
4
CD73 controls ocular adenosine levels and protects retina from light-induced phototoxicity.
Cell Mol Life Sci. 2022 Feb 25;79(3):152. doi: 10.1007/s00018-022-04187-4.
5
Structure-Activity Relationship of 3-Methylcytidine-5'-α,β-methylenediphosphates as CD73 Inhibitors.
J Med Chem. 2022 Feb 10;65(3):2409-2433. doi: 10.1021/acs.jmedchem.1c01852. Epub 2022 Jan 26.
7
The elegant complexity of mammalian ecto-5'-nucleotidase (CD73).
Trends Cell Biol. 2021 Oct;31(10):829-842. doi: 10.1016/j.tcb.2021.05.008. Epub 2021 Jun 8.

本文引用的文献

1
Discovery of AB680: A Potent and Selective Inhibitor of CD73.
J Med Chem. 2020 Oct 22;63(20):11448-11468. doi: 10.1021/acs.jmedchem.0c00525. Epub 2020 Jul 20.
2
The adenosine pathway in immuno-oncology.
Nat Rev Clin Oncol. 2020 Oct;17(10):611-629. doi: 10.1038/s41571-020-0382-2. Epub 2020 Jun 8.
3
4
Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73.
J Med Chem. 2020 Apr 23;63(8):3935-3955. doi: 10.1021/acs.jmedchem.9b01713. Epub 2020 Apr 8.
5
2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5'-nucleotidase (CD73) Inhibitors with Variable Binding Modes.
J Med Chem. 2020 Mar 26;63(6):2941-2957. doi: 10.1021/acs.jmedchem.9b01611. Epub 2020 Feb 28.
6
Adenosine Metabolism: Emerging Concepts for Cancer Therapy.
Cancer Cell. 2019 Dec 9;36(6):582-596. doi: 10.1016/j.ccell.2019.10.007.
7
Ectonucleotidases: Potential Target in Drug Discovery and Development.
Mini Rev Med Chem. 2019;19(11):866-869. doi: 10.2174/138955751911190517102116.
8
An Exceptionally Potent Inhibitor of Human CD73.
Biochemistry. 2019 Aug 6;58(31):3331-3334. doi: 10.1021/acs.biochem.9b00448. Epub 2019 Jul 23.
9
Structure-Activity Relationship of Purine and Pyrimidine Nucleotides as Ecto-5'-Nucleotidase (CD73) Inhibitors.
J Med Chem. 2019 Apr 11;62(7):3677-3695. doi: 10.1021/acs.jmedchem.9b00164. Epub 2019 Mar 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验